Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
VCNX Vaccinex
- 0.950
- -0.030-3.06%
15min DelayClose Jan 2 16:00 ET
2.54MMarket Cap0.13P/E (TTM)
1.000High0.942Low7.70KVolume0.942Open0.980Pre Close7.51KTurnover0.72%Turnover RatioLossP/E (Static)2.68MShares13.02052wk High-0.89P/B1.01MFloat Cap0.76052wk Low--Dividend TTM1.06MShs Float2568.300Historical High--Div YieldTTM5.95%Amplitude0.760Historical Low0.976Avg Price1Lot Size
About Vaccinex Company
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in April 2001 and is headquartered in Rochester, NY.
Company Profile
SymbolVCNX
Company NameVaccinex
Listing DateAug 9, 2018
Issue Price12.00
Founded2001
CEODr. Maurice Zauderer, PhD
MarketPink Market
Employees40
Fiscal Year Ends12-31
Address1895 Mount Hope Avenue
CityRochester
ProvinceNew York
CountryUnited States of America
Zip Code14620
Phone1-585-271-2700
Websitehttp://www.vaccinex.com
Company Executives
- Name
- Position
- Salary
- Dr. Maurice Zauderer, PhD
- Director, President and Chief Executive Officer
- 430.28K
- Dr. Ernest S. Smith, PhD
- Senior Vice President, Research and Chief Scientific Officer
- 308.90K
- Jill Sanchez
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Elizabeth Evans
- Chief Operating Officer and Senior Vice President, Translational Medicine and Discovery
- 303.21K
- Albert D. Friedberg
- Chairman of the Board
- 75.00K
- Gerald E. Van Strydonck
- Independent Director
- 90.00K
- Barbara Yanni
- Independent Director
- 85.00K
- Jacob B. Frieberg
- Independent Director
- 75.00K
- Dr. Bala S. Manian, PhD
- Independent Director
- 82.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.